NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis:: de-novo origin?

被引:13
作者
Pasqualucci, L. [1 ,2 ,3 ]
Li, S. [4 ]
Meloni, G. [5 ]
Schnittger, S. [6 ]
Gattenlohner, S. [7 ]
Liso, A. [8 ]
Di Ianni, M. [1 ]
Martelli, M. P. [1 ]
Pescarmona, E. [5 ]
Foa, R.
Haferlach, T. [6 ]
Skoda, R. C. [4 ]
Falini, B. [1 ]
机构
[1] Univ Perugia, IBit Fdn, Sect Haematol & Immunol, I-06100 Perugia, Italy
[2] Columbia Univ, Inst Canc Genet, Herbert Irving Comprehens Canc Ctr, New York, NY USA
[3] Columbia Univ, Dept Pathol, Herbert Irving Comprehens Canc Ctr, New York, NY USA
[4] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland
[5] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Rome, Italy
[6] MLL Munich Leukemia Lab, Munich, Germany
[7] Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany
[8] Univ Foggia, Inst Haematol, Foggia, Italy
关键词
D O I
10.1038/sj.leu.2405093
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1459 / 1463
页数:6
相关论文
共 12 条
  • [1] Mutation of JAK2 in the myeloproliferative disorders:: timing, clonality studies, cytogenetic associations, and role in leukemic transformation
    Campbell, Peter J.
    Baxter, E. Joanna
    Beer, Philip A.
    Scott, Linda M.
    Bench, Anthony J.
    Huntly, Brian J. P.
    Erber, Wendy N.
    Kusec, Rajko
    Larsen, Thomas Stauffer
    Giraudier, Stephane
    Le Bousse-Kerdiles, Marie-Caroline
    Griesshammer, Martin
    Reilly, John T.
    Cheung, Betty Y.
    Harrison, Claire N.
    Green, Anthony R.
    [J]. BLOOD, 2006, 108 (10) : 3548 - 3555
  • [2] C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders
    Caudill, Jonathan S. C.
    Sternberg, Alexander J.
    Li, Chin-Yang
    Tefferi, Ayalew
    Lasho, Terra L.
    Steensma, David P.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (06) : 638 - 641
  • [3] A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders
    Di Ianni, M.
    Moretti, L.
    Del Papa, B.
    Gaozza, E.
    Bell, A. S.
    Falzetti, F.
    Tabilio, A.
    [J]. LEUKEMIA, 2006, 20 (10) : 1895 - 1897
  • [4] Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
    Falini, B
    Mecucci, C
    Tiacci, E
    Alcalay, M
    Rosati, R
    Pasqualucci, L
    La Starza, R
    Diverio, D
    Colombo, E
    Santucci, A
    Bigerna, B
    Pacini, R
    Pucciarini, A
    Liso, A
    Vignetti, M
    Fazi, P
    Meani, N
    Pettirossi, V
    Saglio, G
    Mandelli, F
    Lo-Coco, F
    Pelicci, P
    Martelli, MF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) : 254 - 266
  • [5] Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features
    Falini, Brunangelo
    Nicoletti, Ildo
    Martelli, Massimo F.
    Mecucci, Cristina
    [J]. BLOOD, 2007, 109 (03) : 874 - 885
  • [6] Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
    Falini, Brunangelo
    Martelli, Maria Paola
    Bolli, Niccolo
    Bonasso, Rossella
    Ghia, Emanuela
    Pallotta, Maria Teresa
    Diverio, Daniela
    Nicoletti, Ildo
    Pacini, Roberta
    Tabarrini, Alessia
    Galletti, Barbara Verducci
    Mannucci, Roberta
    Roti, Giovanni
    Rosati, Roberto
    Specchia, Giorgina
    Liso, Arcangelo
    Tiacci, Enrico
    Alcalay, Myriam
    Luzi, Lucilla
    Volorio, Sara
    Bernard, Loris
    Guarini, Anna
    Amadori, Sergio
    Mandelli, Franco
    Pane, Fabrizio
    Lo-Coco, Francesco
    Saglio, Giuseppe
    Pelicci, Pier-Giuseppe
    Martelli, Massimo F.
    Mecucci, Cristina
    [J]. BLOOD, 2006, 108 (06) : 1999 - 2005
  • [7] Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients
    Gangat, N.
    Wolanskyj, A. P.
    McClure, R. F.
    Li, C-Y
    Schwager, S.
    Wu, W.
    Tefferi, A.
    [J]. LEUKEMIA, 2007, 21 (02) : 270 - 276
  • [8] Detecting the JAK2 V617F mutation in fresh and 'historic' blood and bone marrow
    Gattenlohner, S.
    Peter, C.
    Bonengel, M.
    Einsele, H.
    Bargou, R.
    Muller-Hermelink, H-K
    Marx, A.
    [J]. LEUKEMIA, 2007, 21 (07) : 1599 - 1602
  • [9] Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemias
    Illmer, Thomas
    Schaich, Markus
    Ehniger, Gerhard
    Thiede, Christian
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01): : 137 - 138
  • [10] A gain-of-function mutation of JAK2 in myeloproliferative disorders
    Kralovics, R
    Passamonti, F
    Buser, AS
    Teo, S
    Tiedt, R
    Passweg, JR
    Tichelli, A
    Cazzola, M
    Skoda, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) : 1779 - 1790